Search by Drug Name or NDC
NDC 65162-0913-22 Voriconazole 40 mg/mL Details
Voriconazole 40 mg/mL
Voriconazole is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is VORICONAZOLE.
MedlinePlus Drug Summary
Voriconazole is used in adults and children 2 years of age and older to treat serious fungal infections such as invasive aspergillosis (a fungal infection that begins in the lungs and spreads through the bloodstream to other organs), esophageal candidiasis (a yeast [a type of fungus] infection that may cause white patching in the mouth and throat), and candidemia (a fungal infection in the blood). It is also used to treat certain other fungal infections when other medications will not work for certain patients. Voriconazole is in a class of antifungal medications called triazoles. It works by slowing the growth of the fungi that cause infection.
Related Packages: 65162-0913-22Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Voriconazole
Product Information
| NDC | 65162-0913 |
|---|---|
| Product ID | 65162-913_5d0796f8-7ba9-4212-a72f-26c209049562 |
| Associated GPIs | 11407080001920 |
| GCN Sequence Number | 053774 |
| GCN Sequence Number Description | voriconazole SUSP RECON 200 MG/5ML ORAL |
| HIC3 | W3B |
| HIC3 Description | ANTIFUNGAL AGENTS |
| GCN | 21513 |
| HICL Sequence Number | 023720 |
| HICL Sequence Number Description | VORICONAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | Voriconazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Voriconazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | POWDER, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/mL |
| Substance Name | VORICONAZOLE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205034 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0913-22 (65162091322)
| NDC Package Code | 65162-913-22 |
|---|---|
| Billing NDC | 65162091322 |
| Package | 75 mL in 1 BOTTLE (65162-913-22) |
| Marketing Start Date | 2013-11-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |